Risk factors for adverse drug events: A 10-year analysis

被引:99
作者
Evans, RS
Lloyd, JF
Stoddard, GJ
Nebeker, JR
Samore, MH
机构
[1] LDS Hosp, Dept Med Informat, Salt Lake City, UT 84143 USA
[2] Univ Utah, Sch Med, LDS Hosp & Intermt Hlth Care, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Div Clin Epidemiol, Biostat Sect, Salt Lake City, UT 84112 USA
[4] Univ Utah, Sch Med, Div Clin Epidemiol, Salt Lake City, UT 84112 USA
[5] Univ Utah, Sch Med, Dept Med Informat, Salt Lake City, UT USA
关键词
adverse drug events; quality improvement; risk factors;
D O I
10.1345/aph.1E642
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Many adverse drug events (ADEs) are the result of known pharmacologic properties, and some result from medication errors. However, some are the result of patient-specific risk factors. OBJECTIVE: To identify inpatient risk factors for ADEs. METHODS: Conditional logistic regression was used to analyze all pharmacist-verified ADEs by therapeutic class of drugs and severity during a 10-year study period. All inpatients >= 18 years of age from a 520-bed tertiary teaching hospital were included. Each case patient was matched with up to 16 control patients. Odds ratios for patient factors associated with ADEs were calculated from different therapeutic classes of drugs. RESULTS: Odds ratios for numerous risk factors were identified for 4376 ADEs and were found to vary depending on therapeutic classification. The risk factors for the different classifications were grouped by (1) patient characteristics-female (OR 1.5-1.7), age (0.7-0.9), weight (1.2-1.4), creatinine clearance (0.8-4.7), and number of comorbidities (1.1-12.6); (2) drug administration-dosage (1.2-3.7), administration route (1.4-149.9), and number of concomitant drugs (1.2-2.4); and (3) patient type-service (1.2-4.9), nursing division (1.5-3.8), and diagnosis-related group (1.5-5.7). CONCLUSIONS: Some risk factors are consistent for all ADEs and across multiple therapeutic classes of drugs, while others are class specific. High-risk agents should be closely monitored based on patient characteristics (gender, age, weight, creatinine clearance, number of comorbidities) and drug administration (dosage, administration route, number of concomitant drugs).
引用
收藏
页码:1161 / 1168
页数:8
相关论文
共 34 条
  • [1] Evaluating the capability of information technology to prevent adverse drug events: A computer simulation approach
    Anderson, JG
    Jay, SJ
    Anderson, M
    Hunt, TJ
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2002, 9 (05) : 479 - 490
  • [2] INCIDENCE AND PREVENTABILITY OF ADVERSE DRUG EVENTS IN HOSPITALIZED ADULTS
    BATES, DW
    LEAPE, LL
    PETRYCKI, S
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1993, 8 (06) : 289 - 294
  • [3] Effect of computerized physician order entry and a team intervention on prevention of serious medication errors
    Bates, DW
    Leape, LL
    Cullen, DJ
    Laird, N
    Petersen, LA
    Teich, JM
    Burdick, E
    Hickey, M
    Kleefield, S
    Shea, B
    Vander Vliet, M
    Seger, DL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (15): : 1311 - 1316
  • [4] Detecting adverse events using information technology
    Bates, DW
    Evans, RS
    Murff, H
    Stetson, PD
    Pizziferri, L
    Hripcsak, G
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2003, 10 (02) : 115 - 128
  • [5] Patient risk factors for adverse drug events in hospitalized patients
    Bates, DW
    Miller, EB
    Cullen, DJ
    Burdick, L
    Williams, L
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Vander Vliet, M
    Leape, LL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) : 2553 - 2560
  • [6] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34
  • [7] The costs of adverse drug events in hospitalized patients
    Bates, DW
    Spell, N
    Cullen, DJ
    Burdick, E
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Leape, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04): : 307 - 311
  • [8] MULTIPLICATIVE MODELS AND COHORT ANALYSIS
    BRESLOW, NE
    LUBIN, JH
    MAREK, P
    LANGHOLZ, B
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1983, 78 (381) : 1 - 12
  • [9] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [10] The effects of nurse staffing on adverse events, morbidity, mortality, and medical costs
    Cho, SH
    Ketefian, S
    Barkauskas, VH
    Smith, DG
    [J]. NURSING RESEARCH, 2003, 52 (02) : 71 - 79